Literature DB >> 16302171

Genotoxic effects of extremely low frequency (ELF) magnetic fields (MF) evaluated by the Tradescantia-micronucleus assay.

Cristina Fatigoni1, Luca Dominici, Massimo Moretti, Milena Villarini, Silvano Monarca.   

Abstract

Extremely low frequency (ELF) electric fields (EF) and magnetic fields (MF) are generated during the production, transmission, and use of electrical energy. Although epidemiology studies suggest that there is a cancer risk associated with exposure to ELF-MF, short-term genotoxicity assays with bacteria and mammalian cells have produced inconsistent results. In the present study, we investigated the possible genotoxicity of ELF-MF by using the Tradescantia-micronucleus (Trad-MN) assay, a sensitive, reproducible, well-standardized assay for genotoxicity testing. A 50 Hz ELF-MF was generated by a laboratory exposure system consisting of a pair of parallel coils in a Helmholtz configuration. Exposure of Tradescantia (clone # 4430) inflorescences to the ELF-MF, at a flux density (B) corresponding to 1 mT, for 1, 6, and 24 h resulted in a time-dependent increase in MN frequency. The results indicate that a 50 Hz MF of 1 mT field strength is genotoxic in the Trad-MN bioassay and suggest that this assay may be suitable as a biomonitor for detecting the genotoxicity of ELF-MF in the field. Copyright (c) 2005 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2005        PMID: 16302171     DOI: 10.1002/tox.20148

Source DB:  PubMed          Journal:  Environ Toxicol        ISSN: 1520-4081            Impact factor:   4.119


  2 in total

1.  Retinoic acid inhibits the cytoproliferative response to weak 50‑Hz magnetic fields in neuroblastoma cells.

Authors:  María Ángeles Trillo; María Antonia Martínez; María Antonia Cid; Alejandro Úbeda
Journal:  Oncol Rep       Date:  2012-12-24       Impact factor: 3.906

2.  Effect of ELF-EMF Exposure on Human Neuroblastoma Cell Line: a Proteomics Analysis.

Authors:  Hadi Hasanzadeh; Mostafa Rezaie-Tavirani; Samaneh Sadat Seyyedi; Hakimeh Zali; Saeid Heydari Keshel; Majid Jadidi; Ali Abedelahi
Journal:  Iran J Cancer Prev       Date:  2014
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.